Top Markets
Coin of the day
Shine-On BioMedical Co.,Ltd. Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd.

6926
Rank in Stocks #21821
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and... Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Share Price
$2.00
Last synced: 2026-08-20
Market Cap
$99.77M
Change (1 day)
-0.47%
Change (1 year)
-15.35%
Country
TW
Trade Shine-On BioMedical Co.,Ltd. (6926)

Category

Earnings for Shine-On BioMedical Co.,Ltd. (6926)
Earnings in 2026 TTM: 0
According to Shine-On BioMedical Co.,Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Shine-On BioMedical Co.,Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$-4.02B -
AU
- -
CH